Leurgans, Sue; Shannon, Kathleen M. The Montreal Cognitive Assessment as a screening tool for cognitivedysfunction in Huntington's disease. Movement Disorders
(页面存档备份,存于互联网档案馆) (英文)FDA Qualified Health Claim Phosphatidylserine and CognitiveDysfunction and Dementia (页面存档备份,存于互联网档案馆) (英文)醫學主題詞表(MeSH):Phosphatidylserines
Muller, GW. Myeku, Natura. Tau-driven 26S proteasome impairment and cognitivedysfunction can be prevented early in disease by activating cAMP-PKA signaling